Status:
UNKNOWN
Risk Factors for Multidrug Resistant Bacteria at ICU Admission
Lead Sponsor:
José Raimundo Araujo de Azevedo
Conditions:
Multi Drug Resistant Bacteria
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this single-center prospective observational study is to evaluate possible independent risk factors for multidrug-resistant (MDR) bacteria upon ICU admission by analyzing comorbiditie...
Detailed Description
Background: Infection is one of the main reason for a patient to be admitted to an intensive care unit (ICU) and it's fundamental to use the right antibiotic as soon as possible, possibly needing broa...
Eligibility Criteria
Inclusion
- All patients admitted to the ICU with an infectious disease initiated within 48 hours of hospital admission and a microbiological positive result for bacteria
Exclusion
- Patients with results considered as contamination according to the institutional protocol.
- Surgical wound and bloodstream infections.
- Microbiological isolation of only fungi.
- Vigilance cultures, such as anal, rectal, nasal, and axillary swabs.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05983861
Start Date
September 1 2023
End Date
January 31 2025
Last Update
August 9 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.